Navigation Links
Brooks and the University of Florida Reach Research Agreement
Date:12/10/2007

JACKSONVILLE, Fla., Dec. 10 /PRNewswire-USNewswire/ -- Brooks Rehabilitation and the University of Florida have reached a new five-year agreement that will position the Brooks Center for Rehabilitation Studies, in collaboration with UF, as a world-class research facility.

The agreement increases funding for the Brooks Center by more than $5 million over five years. As part of its Community Benefit initiative, Brooks will provide $4 million in funding and UF, through its Health Science Center colleges, will provide more than $1 million. The funding will be used to support research taking place in both Brooks' and UF facilities.

"We are pleased to further develop our relationship with the University of Florida and look forward to the increased research capabilities we will share," said Brooks CEO & president, Doug Baer. "Our investment in the Center's growth will bring the latest innovations to our patients."

Robert C. Nuss, M.D., dean of the regional campus at the UF Health Science Center-Jacksonville, cited the excellent opportunity the expanded relationship offers Brooks and UF. "The benefits are tremendous for both parties, with the Center's research projects focusing primarily on stroke and other neurological conditions, relating to the population served by both Brooks and UF," he said. "In addition, this arrangement provides an excellent opportunity for us to maximize collaboration between our own Gainesville and Jacksonville campuses."

The agreement will result in the addition of six dedicated, doctoral-level researchers and support staff working at the Brooks Center and at UF Health Science Center-Jacksonville. Now that the agreement is finalized, the search for a full-time Brooks Center director will begin.

The Center's mission and vision include a focus on research and improvement of the continuum of care, leading to optimal outcomes and functional improvements for its patients. More than 20 active research
'/>"/>

SOURCE Brooks Rehabilitation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. More Efficient, Effective and Personal Patient Care at New McCune-Brooks Hospital Made Possible by Siemens HiPath(R) Wireless
2. University of Iowa professor identifies new eating disorder
3. University of Wisconsin Hospitals and Clinics Complete System-Wide Conversion to Masimo SET Pulse Oximetry Technology
4. University of Texas Study Details Lengthy Payment Delays for Medicare Part D Prescription Drug Claims, Confirming Need for Legislative Fix
5. Tulane University to receive $14M for international HIV/AIDS program
6. University of Nevada School of Medicine Professor Confirms Accuracy Through Validation Study Using the CSI Health Station Model 6K
7. Boston University School of Medicine researcher recipient of Memory Ride Grant
8. Loma Linda University Medical Center Selects Beryl to Manage Call Center Interactions for Womens Services Programs and Departments
9. Medina General Hospital and University Hospitals Agree to Pursue Affiliation
10. J.D. Power and Associates Reports: Hackensack University Medical Center Recognized as First Hospital to Achieve Distinction for Providing an Outstanding Inpatient Experience in All Four Service Areas
11. The First Incisionless Transoral Fundoplication for Treatment of Gastroesophageal Reflux is Performed in the U.S. at Ohio State University and Oregon Health & Science University Medical Centers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...esults of a 10-year study published in the August ...found that magnesium sulfate administered to women...he risk of cerebral palsy by 50 percent. The Benef...) trial was conducted in 18 centers in the U.S., i...renatal intervention ever found to reduce the inst...
(Date:8/29/2008)... http://www.aronowitzmd.com [Los An...espected experience in plastic surgery procedures ...consideration may be necessary for these patients,...e an established specialty of procedures for after...es, CA (PRWEB) August 29, 2008 -- Bariatric surger...
(Date:8/28/2008)...ues increase 138% versus Q2 2007 - Nine new Cen...RNewswire-FirstCall/ - CRH Medical Corporation,(CR... three and six months,ended June 30, 2008 (all fig...ths ended June 30, 2008 increased 138% to $1,653,8...7. Revenue for the six months ended June,30, 2008 ...
(Date:8/28/2008)...ion will be based in the Northeast region with mor...xt year, HARRISBURG, Pa., Aug. 28 /PRNewswire-USN...ity has hired a Patient Safety Liaison for the,Nor...eport to the,Pennsylvania Patient Safety Reporting...ylvania citizens., "Last year in focus groups wit...
Breaking Medicine News(10 mins):Health News:National study shows magensium sulfate reduces risk of cerebral palsy in premature births 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 3Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 4Health News:CRH Medical reports Q2 2008 results 2Health News:CRH Medical reports Q2 2008 results 3Health News:CRH Medical reports Q2 2008 results 4Health News:CRH Medical reports Q2 2008 results 5Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 2Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 3
...ls about how proteins used to destroy bacteria and...nar K. Gouras, associate professor of neurology an... University, New York, and colleagues provide new ...alled antibodies, reduce the main hallmarks of Alz...
... scientific method for testing and measuring xanth...nducted on XanGo Juice , indicate usage of the who... high xanthone absorption. XanGo, LLC, recognized...t category is leading scientific exploration of th...
...ng all possible arrangements to look good on her y...o sources, the first thing that the socialite will... dry face. Hilton has resentfully complained to t...that she's not permitted to have facial moisturize...
...y who were destined to go blind within five years ...treatment with Avastin , a well-known cancer drug,...ne, 2007 Archives of Ophthalmology. This is a majo...ts who are treated with radiation therapy and comm...
Other Medicine News:Health News:Researchers Link Bacteria Destroying Proteins to Alzheimer's Treatment 2Health News:Researchers Link Bacteria Destroying Proteins to Alzheimer's Treatment 3Health News:New Technique to Measure Xanthone in Mangosteen 2Health News:New Technique to Measure Xanthone in Mangosteen 3Health News:Untreatable Eye Disease Improves With Avastin 2
(Date:8/25/2008)...t and Japanese Development Studies ...ust 25 /- Genmab has,announ...hronic lymphocytic,leukemia and non-Hodgkin,s lymp...s to begin four studies of,ofatumumab in chronic l...in,s lymphoma (NHL) this year., "Genmab and GSK h...
(Date:8/22/2008)...FirstCall/ -- Human Genome,Sciences, Inc. (Nasdaq:...,enrollment and initial dosing of patients in a ra...n combination with the chemotherapy agents,paclita...ced non-small cell,lung cancer (NSCLC)., (Logo: ...GO ), "There is an urgent medical need for effec...
(Date:8/21/2008)...-USNewswire/ -- Dangerous disease,often spreads fa...emedy,that, researchers at Kansas State University...s down to hours., Sanjeev Narayanan, assistant pr...t, both in the department of diagnostic medicine a... microarray to seek out the,specific genetic marke...
(Date:8/21/2008)...re-FirstCall/ -- Telik, Inc.,(Nasdaq: TELK ) anno...me,inhibitor program met a preclinical development... preclinical models of human leukemia. The proteas...or the growth and function of,cancer cells and inh...e,cell cycle arrest and cancer cell death or apopt...
Breaking Medicine Technology:Genmab Announces Upcoming Ofatumumab Studies 2Genmab Announces Upcoming Ofatumumab Studies 3Genmab Announces Upcoming Ofatumumab Studies 4Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 2Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 3Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 4Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 5Rapid Test for Pathogens Developed By K-State Researchers Could Be Used to Detect Diseases Used By Bioterrorists 2Telik's Proteasome Inhibitor Program Meets a Preclinical Development Milestone 2To catch a panda 1538 1To catch a panda 1538 2Massive dinosaur discovered in Antarctica sheds light on life distribution of sauropodomorphs 1533 1Massive dinosaur discovered in Antarctica sheds light on life distribution of sauropodomorphs 1533 2CRi Announces Nuance 2 the Next Generation Multispectral Imaging System for Brightfield and Fluorescent Based Microscopy 2122 1CRi Announces Nuance 2 the Next Generation Multispectral Imaging System for Brightfield and Fluorescent Based Microscopy 2122 2New Report Offers Hope for Closing Health Gap for African Americans With Nearly 700 Medicines in Pipeline 1026 1New Report Offers Hope for Closing Health Gap for African Americans With Nearly 700 Medicines in Pipeline 1026 2New Report Offers Hope for Closing Health Gap for African Americans With Nearly 700 Medicines in Pipeline 1026 3
...fficacy in broad range,of patients and across cont.../PRNewswire-FirstCall/ --,Millennium Pharmaceutica...e market leading therapy with unsurpassed single-a... multiple myeloma,(MM), will be featured at the up..., Greece, June 25-30, 2007. , "Clinical data to be...
...ll/ -- Vical,Incorporated today announced that the...ive results following interim analysis of data,fro...l of an,angiogenesis product candidate using Vical...that the primary efficacy,endpoint in the trial ha...that there were no major safety concerns related,t...
Other Medicine Technology:Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 2Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 3Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 4Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 5Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 6Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 7Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 8Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 2Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 3Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 4Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 5
...ld, point-of-care device for the qualitative detec...The TOX/See device can detect up to nine of the mo...uires only a few drops of urine. Each TOX/See cass...nce and ease of use. TOX/See features integrated t...
...ld, point-of-care device for the qualitative detec...The TOX/See device can detect up to nine of the mo...uires only a few drops of urine. Each TOX/See cass...nce and ease of use. TOX/See features integrated t...
...ld, point-of-care device for the qualitative detec...The TOX/See device can detect up to nine of the mo...uires only a few drops of urine. Each TOX/See cass...nce and ease of use. TOX/See features integrated t...
...ld, point-of-care device for the qualitative detec...The TOX/See device can detect up to nine of the mo...uires only a few drops of urine. Each TOX/See cass...nce and ease of use. TOX/See features integrated t...
Medicine Products: